Sales, Lea Mae .
HRN: 28-14-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2026
CO-AMOXICLAV 625MG (TAB)
03/27/2026
04/03/2026
PO
625mg/tab
TID
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: